Zhejiang Doer Biologics Co.,Ltd.
About Doer Biologics
Founded in 2014, Zhejiang Doer Biologics Co., Ltd is a
clinical-stage biopharmaceutical company with its R&D
center located in Hangzhou, China. Powered by its
proprietary xLONGylation, MultipleBody, AccuBody,
and SMART-VHHBody technology platforms, Doer
Biologics is developing innovative multi-domain based
multi-specific therapeutic proteins. Doer Biologics'
highly differentiated pipeline focuses on unmet clinical
needs in the fields of cancer, endocrinology, metabolic
diseases, and ophthalmology. To learn more about Doer
Biologics, please visit the company website: